Evgen Pharma Plc’s £3.4 Million Acquisition of Majority Stake in Chronos Therapeutics Ltd

Marco Zingaro
Tagged:

Clyde & Co advised Chronos Therapeutics Limited on the deal.Evgen Pharma plc (AIM:EVG) agreed to acquire Chronos Therapeutics Ltd. for £3.4 million. The total consideration for…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here